I’m delighted to know you want to go on a date with me!
How about you get to know me a little better?
I’d like to introduce myself as Diabetes.
I love unhealthy food and hate being active.
A typical day with me would be lazing on the couch and hogging on some cheese burgers and fries the whole day.
Symptoms of our relationship:
Hunger- more than usual
Frequently thirsty/ Dry mouth
Boils/blisters erupting over skin/itchy skin
Slow healing wounds
Pain/numbness of feet and legs
Unplanned weight loss
A relationship with me is harmful
and long term. Don't let yourself get into one.
Here’s how you can lead a healthy and happy life without me!
Eat foods low in sugar and rich in fiber
Go for regular walks and engage in physical activity
Avoid aerated drinks and have more water
Go for regular health check ups
It is always wise to periodically test your sugar level by taking the following tests: Fasting blood sugar, HB1Ac and HOMA Index.
Take the pledge to fight diabetes by tweeting #NotMyType
Save tax on the Preventive health check-ups up to Rs. 5000, under section 80D of Income Tax Act, 1961
We are Metropolis - Your Pathology Specialist
Metropolis is one of the leading diagnostics companies in India, by revenue, as of March 31, 2018 (Source: Frost & Sullivan). With operations across India, Africa, South Asia and Middle East.
Our globally accredited clinical laboratories deliver millions of accurate and timely test results every year. We offer a comprehensive range of clinical laboratory tests and profiles which are used in prediction, early detection, diagnostic screening, confirmation and monitoring of diseases.
Delivering diagnostic services since 1980
Network of 100+ clinical labs & 1100+ patient touch points
Qualified team of phlebotomists for Home collection services
Certified NABL and CAP accredited labs
Wide range of 4000+ tests & profiles
Convenience of home collection service
Metropolis Healthcare Limited is proposing subject to applicable statutory or regulatory requirements, receipt of requisite approvals, market conditions and other considerations to undertake an initial public offering of its equity shares and has filed a draft red herring prospectus dated September 27, 2018 (“DRHP”) with the Securities and Exchange Board of India (“SEBI”). The DRHP is available on the website of the SEBI at www.sebi.gov.in, BSE Limited at www.bseindia.com, National Stock Exchange of India Limited at www.nseindia.com and the websites of Book Running Lead Managers at www.jmfl.com, www.credit-suisse.com, www.investmentbank.kotak.com, www.hdfcbank.com and www.goldmansachs.com. Any potential investors should note that investment in equity shares involves a high degree of risk and for details relating to same, please refer to the DRHP including the section “Risk Factors” of the DRHP. Potential investors should not rely on the DRHP filed with the SEBI for making any investment decision.